Personas / Equipo Humano

Cinzia Emilia Lavarino

Buscador de publicaciones

Publicaciones

  • Morales-La Madrid A, Volchenboum S, Gastier-Foster JM, Pyatt R, Liu D, Pytel P, Lavarino C, Rodriguez E and Cohn SL.

    Locoregional MYCN-amplified neuroblastoma

    PEDIATRIC BLOOD & CANCER . 59(4): 736-738.

    [doi:10.1002/pbc.24003]

  • Garcia I, Mayol G, Ríos J, Domenech G, Cheung NK, Oberthuer A, Fischer M, Maris JM, Brodeur GM, Hero B, Rodriguez E, Suñol M, Galvan P, de Torres C, Mora J and Lavarino C.

    A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma

    CLINICAL CANCER RESEARCH . 18(7): 2012-2023. Nº de citas: 55

    [doi:10.1158/1078-0432.CCR-11-2483]

  • Acosta S, Mayol G, Rodriguez E, Lavarino C, de Preter K, Kumps C, Garcia I, de Torres C and Mora J.

    Identification of tumoral glial precursor cells in neuroblastoma

    CANCER LETTERS . 312(1): 73-81. Nº de citas: 12

    [doi:10.1016/j.canlet.2011.08.004]

  • Garcia I, Mayol G, Rodriguez E, Suñol M, Gershon TR, Ríos J, Cheung NK, Kieran MW, George RE, Perez-Atayde AR, Casalà C, Galván P, de Torres C, Mora J and Lavarino C.

    Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma

    MOLECULAR CANCER . 9: 277-277. Nº de citas: 58

    [doi:10.1186/1476-4598-9-277]

  • De Preter K, Vermeulen J, Brors B, Delattre O, Eggert A, Fischer M, Janoueix-Lerosey I, Lavarino C, Maris JM, Mora J, Nakagawara A, Oberthuer A, Ohira M, Schleiermacher G, Schramm A, Schulte JH, Wang Q, Westermann F, Speleman F and Vandesompele J.

    Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

    CLINICAL CANCER RESEARCH . 16(5): 1532-1541. Nº de citas: 76

    [doi:10.1158/1078-0432.CCR-09-2607]

  • de Torres C, Beleta H, Díaz-Naderi R, Toran N, Rodríguez E, Lavarino C, García I, Acosta S, Suñol M and Mora J.

    The Calcium-Sensing Receptor and Parathyroid Hormone-related Protein Are Expressed in Differentiated, Favorable Neuroblastic Tumors

    CANCER . 115(12): 2792-2803. Nº de citas: 24

    [doi:10.1002/cncr.24304]

  • Acosta S, Lavarino C, Paris R, Garcia I, de Torres C, Rodríguez E, Beleta H and Mora J.

    Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells

    BMC DEVELOPMENTAL BIOLOGY . 9: 12-12. Nº de citas: 50

    [doi:10.1186/1471-213X-9-12]

  • Lavarino C, Cheung NK, Garcia I, Domenech G, de Torres C, Alaminos M, Rios J, Gerald WL, Kushner B, LaQuaglia M and Mora J.

    Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma

    BMC Cancer . 9: 44-44. Nº de citas: 27

    [doi:10.1186/1471-2407-9-44]

  • Lavarino C, Garcia I, Mackintosh C, Cheung NK, Domenech G, Ríos J, Perez N, Rodríguez E, de Torres C, Gerald WL, Tuset E, Acosta S, Beleta H, de Alava E and Mora J.

    Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status

    BMC MEDICAL GENOMICS . 1: 36-36. Nº de citas: 11

    [doi:10.1186/1755-8794-1-36]

  • Mora J, Lavarino C, Alaminos M, Cheung NK, Ríos J, de Torres C, Illei P, Juan G and Gerald WL.

    Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma

    GENES CHROMOSOMES & CANCER . 46(4): 385-396. Nº de citas: 7

    [doi:10.1002/gcc.20421]